News & Events

Zahrawi Group together with our partner Monrol-UAE, participated in Advances in Nuclear Medicine: Precision Imaging & Therapy 2026 hosted by Burjeel Cancer Institute | BCI, held at Rosewood Hotel, Abu Dhabi, UAE.

The event brought together leading experts and innovators in nuclear medicine to explore cutting-edge developments in imaging, diagnostics, and theranostics.

During the event, our team highlighted a comprehensive portfolio from our partner Monrol UAE, a GMP-certified facility, encompassing a wide range of products, including F-18 and n.c.a. Lutetium-177, in addition to specialized project management services.

Moreover, solutions from our partner OncoSil were presented, featuring the intratumoural delivery of Phosphorus-32 (P-32) as an innovative approach for the treatment of locally advanced pancreatic cancer.

In addition, a satellite symposium sponsored by Zahrawi Group in collaboration with our partner Monrol-UAE took place during the event, featuring a presentation by Prof. Akram Al-Ibraheem, Chairman of the Nuclear Medicine and PET/CT Department at King Hussein Cancer Center, Jordan.